Disposition of 14892 shares by Romano Gary of Alector at 2.5194 subject to Rule 16b-3
ALEC Stock | USD 1.78 0.04 2.20% |
About 68% of Alector's investor base is looking to short. The analysis of the overall investor sentiment regarding Alector suggests that many traders are alarmed. The current market sentiment, together with Alector's historical and current headlines, can help investors time the market. In addition, many technical investors use Alector stock news signals to limit their universe of possible portfolio assets.
Alector |
Filed transaction by Alector Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at gurufocus.com
Alector Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Alector can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Alector Fundamental Analysis
We analyze Alector's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alector based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Alector is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Alector Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alector stock to make a market-neutral strategy. Peer analysis of Alector could also be used in its relative valuation, which is a method of valuing Alector by comparing valuation metrics with similar companies.
Peers
Alector Related Equities
PASG | Passage Bio | 1.54 | ||||
LRMR | Larimar Therapeutics | 1.00 | ||||
STOK | Stoke Therapeutics | 1.60 | ||||
GLUE | Monte Rosa | 2.22 | ||||
RVMD | Revolution Medicines | 2.38 | ||||
BDTX | Black Diamond | 4.78 | ||||
CABA | Cabaletta Bio | 8.03 |
Complementary Tools for Alector Stock analysis
When running Alector's price analysis, check to measure Alector's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alector is operating at the current time. Most of Alector's value examination focuses on studying past and present price action to predict the probability of Alector's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alector's price. Additionally, you may evaluate how the addition of Alector to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |